Neuroleptic Malignant Syndrome: Diagnosis and Management.
Ware MR, Feller DB, Hall KL.
Prim Care Companion CNS Disord. 2018 Jan 4;20(1):17r02185. doi: 10.4088/PCC.17r02185.
Neuroleptic Malignant Syndrome.
Pileggi DJ, Cook AM.
Ann Pharmacother. 2016 Nov;50(11):973-981. doi: 10.1177/1060028016657553. Epub 2016 Jul 19.
Neuroleptic malignant syndrome and serotonin syndrome.
Tormoehlen LM, Rusyniak DE.
Handb Clin Neurol. 2018;157:663-675. doi: 10.1016/B978-0-444-64074-1.00039-2.
Serotonin syndrome vs neuroleptic malignant syndrome: a contrast of causes, diagnoses, and management.
Perry PJ, Wilborn CA.
Ann Clin Psychiatry. 2012 May;24(2):155-62.
Neuroleptic malignant syndrome.
Moscovich M, Nóvak FT, Fernandes AF, Bruch T, Tomelin T, Nóvak EM, Munhoz RP, Teive HA.
Arq Neuropsiquiatr. 2011 Oct;69(5):751-5. doi: 10.1590/s0004-282x2011000600005.
Neuroleptic malignant syndrome.
Caroff SN, Mann SC.
Med Clin North Am. 1993 Jan;77(1):185-202. doi: 10.1016/s0025-7125(16)30278-4.
Neuroleptic malignant syndrome.
Adnet P, Lestavel P, Krivosic-Horber R.
Br J Anaesth. 2000 Jul;85(1):129-35. doi: 10.1093/bja/85.1.129.
Neuroleptic malignant syndrome.
Kornhuber J, Weller M.
Curr Opin Neurol. 1994 Aug;7(4):353-7. doi: 10.1097/00019052-199408000-00013.
Quetiapine-Induced Neuroleptic Malignant Syndrome.
Saraiva R, Côrte-Real B, Cordeiro C, Gonçalves MJ, Abreu M, Coentre R.
Prim Care Companion CNS Disord. 2023 Mar 23;25(2):22cr03332. doi: 10.4088/PCC.22cr03332.
Atypical neuroleptic malignant syndrome: A systematic review of case reports.
Singhai K, Kuppili PP, Nebhinani N.
Gen Hosp Psychiatry. 2019 Sep-Oct;60:12-19. doi: 10.1016/j.genhosppsych.2019.06.009. Epub 2019 Jun 20.
